Enhanced Vaccine Effectiveness during the Delta Phase of the COVID-19 Pandemic in the Medicare Population Supports a Multilayered Prevention Approach.

Experton, Bettina; Elena, Adrien; Hein, Christopher S; Nordenberg, Dale; Walker, Peter; Schwendiman, Blake; Burrow, Christopher R

Experton, Bettina; Elena, Adrien; Hein, Christopher S; Nordenberg, Dale; Walker, Peter; Schwendiman, Blake; Burrow, Christopher R.

Afiliación

Experton B; Humetrix Inc., Del Mar, CA 90214, USA.
Elena A; Humetrix Inc., Del Mar, CA 90214, USA.
Hein CS; Humetrix Inc., Del Mar, CA 90214, USA.
Nordenberg D; Thriive, Inc., Bronx, NY 10463, USA.
Walker P; US Navy, Washington, DC 20376, USA.
Schwendiman B; Humetrix Inc., Del Mar, CA 90214, USA.
Burrow CR; Humetrix Inc., Del Mar, CA 90214, USA.

Biology (Basel) ; 11(12)2022 Nov 24.

Article en En | MEDLINE | ID: mdl-36552210

Palabras clave

B.1.617.2; BNT162b2 vaccine; COVID-19/breakthrough infection; COVID-19/epidemiology/prevention & control; Delta variant; Medicare; SARS CoV-2; aged 65 and over; mRNA-1273 vaccine; multilayered prevention; vaccine effectiveness

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Biology (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google